# Quantitative Reference Models: Lymphatic Transport & Pharmacokinetics of Infused *Glycyrrhiza glabra*

This repository hosts advanced physiological reference documentation, mass transport equations, and pharmacokinetic modeling frameworks evaluating the targeting mechanics of infused licorice (*Glycyrrhiza glabra*) active metabolites within human lymphatic networks. 

The primary scientific objective of this project is to model how primary triterpenoid saponins—specifically **glycyrrhizin (GL)** and its principal bioactive metabolite **18β-glycyrrhetinic acid (GA)**—partition into interstitial fluid grids and accumulate inside regional lymph node matrices.

---

## ⚖️ Regulatory Notice & Repository Governance
To preserve complete alignment with GitHub Trust & Safety standards, FDA software data policies, and institutional healthcare guidelines, this repository enforces strict operational parameters:

* **Pure Formulaic Models:** All biological calculations, transport tensors, and concentration curves detailed within this repository rely exclusively on established mathematical rules, thermodynamic bounds, and peer-reviewed pharmacokinetic formulas. 
* **Absolute PHI Exclusion:** This codebase maintains an airtight barrier against individual patient data. Absolutely **no Protected Health Information (PHI)**, live hospital database telemetry, or individual clinical tracking metrics are accepted or stored. All system test routines use strictly synthetic, generalized baseline variables.
* **Non-Device Educational Reference:** This project serves strictly as an educational text reference, academic research module, and general wellness analysis framework. It does not constitute an active medical device and must never be deployed for real-time patient diagnosis, clinical triaging, or direct autonomous therapeutic dosing.

---

## 🔬 Mathematical Modeling of Lymphatic Targeting (Extended LaTeX)

The systemic absorption, interstitial convective fluid transit, and nodal partitioning of infused botanical constituents are modeled below using advanced transport phenomena equations.

### 1. Enzymatic Hydrolysis & Metabolic Conversion Kinetics
Following ingestion or infusion, the parent compound glycyrrhizin ($\text{GL}$) undergoes localized deglycosylation to yield the highly lipophilic active metabolite 18β-glycyrrhetinic acid ($\text{GA}$). This conversion rate is modeled using a non-linear Michaelis-Menten kinetic framework to prevent saturation estimation errors:

$$\frac{d[\text{GA}]}{dt} = \frac{V_{\max} \cdot [\text{GL}]}{K_m + [\text{GL}]} - k_e \cdot [\text{GA}]$$

Where:
* $V_{\max}$ is the maximum metabolic hydrolysis velocity of the tissue medium ($\text{mg/L} \cdot \text{hr}^{-1}$).
* $K_m$ is the Michaelis constant representing the substrate concentration at half-maximal velocity ($\text{mg/L}$).
* $[\text{GL}]$ and $[\text{GA}]$ are the localized concentrations of the parent saponin and active metabolite, respectively.
* $k_e$ is the primary baseline elimination rate constant ($\text{hr}^{-1}$).

### 2. Transvascular Fluid Flux & Interstitial Lymphatic Influx
The passive movement of the botanical metabolite from peripheral vascular systems into the interstitial fluid space—which directly feeds the initial lymphatic capillaries—is dictated by the extended Starling transport framework:

$$J_v = K_f \left[ (P_{\text{cap}} - P_{\text{if}}) - \sigma (\pi_{\text{cap}} - \pi_{\text{if}}) \right]$$

To evaluate the actual mass flow rate ($J_s$) of the solute ($\text{GA}$) moving via convection and diffusion across the endothelial boundaries into the lymphatic tracking grid, we apply the standard convective-diffusive equation:

$$J_s = P_s \cdot S \cdot \Delta C + J_v \cdot (1 - \sigma_f) \cdot C_{\text{mean}}$$

Where:
* $J_v$ is the net transvascular volumetric fluid flux ($\text{mL/min}$).
* $K_f$ is the hydraulic filtration coefficient of the regional capillary bed ($\text{mL/min} \cdot \text{mmHg}^{-1}$).
* $P_{\text{cap}}$ and $P_{\text{if}}$ are the hydrostatic pressures of the capillary lumen and interstitial fluid, respectively ($\text{mmHg}$).
* $\sigma$ and $\sigma_f$ represent the oncotic and solvent-drag reflection coefficients of the membrane boundaries.
* $\pi_{\text{cap}}$ and $\pi_{\text{if}}$ represent the corresponding capillary and interstitial oncotic pressures ($\text{mmHg}$).
* $P_s$ is the specific permeability coefficient of the metabolite ($\text{cm/s}$), $S$ is the total available surface area ($\text{cm}^2$), and $\Delta C$ is the transvascular concentration gradient.

### 3. Lymph Node Nodal Compartmental Mass Balance
Once the active botanical fractions cross into the afferent lymphatic channels, they enter the functional cellular architecture of the regional lymph nodes (cortex, paracortex, and medulla). The temporal rate of change of metabolite concentration inside a single lymph node compartment ($\frac{dC_{\text{node}}}{dt}$) is governed by a dynamic multi-compartment mass balance balance equation:

$$V_{\text{node}} \frac{dC_{\text{node}}}{dt} = \left( Q_{\text{lymph}} \cdot C_{\text{afferent}} \right) - \left( Q_{\text{lymph}} \cdot C_{\text{efferent}} \right) - \left( K_b \cdot C_{\text{node}} \cdot R \right) - \left( Cl_{\text{nodal}} \cdot C_{\text{node}} \cdot V_{\text{node}} \right)$$

Where:
* $V_{\text{node}}$ is the calculated total anatomical volume capacity of the target regional lymph node network ($\text{cm}^3$).
* $Q_{\text{lymph}}$ is the active volumetric flow velocity of the lymphatic fluid stream ($\text{mL/min}$).
* $C_{\text{afferent}}$ is the incoming solute concentration entering via upstream afferent lymphatic vessels ($\text{mg/L}$).
* $C_{\text{efferent}}$ is the residual solute concentration exiting via the downstream efferent lymphatic pathways ($\text{mg/L}$).
* $K_b$ is the thermodynamic affinity binding constant of the metabolite to regional target structural receptors or cellular matrices.
* $R$ is the available un-bonded regional node cellular receptor density parameter.
* $Cl_{\text{nodal}}$ is the localized metabolic clearance, cellular ingestion, or destruction rate factor within the node's immune cells.

---

## 📂 Repository Architecture & Technical Assets
This repository organizes its educational documents, simulation parameters, and safety models systematically:

* `/docs/Core_Lymphatic_Licorice_Tracking.pdf`: Core clinical education and reference framework detailing *Glycyrrhiza glabra* metabolites.
* `/docs/Core_Lymphatic_Licorice_Tracking.docx`: Editable text script and scientific curriculum outline.
* `app.py`: Standalone Python Tkinter application executing these structural LaTeX mass transport and clearance models.
* `DISCLAIMER.md`: Primary dataset privacy protection statement and mathematical modeling boundary agreement.
* `DISCLAIMER_GENERAL_REFERENCE.md`: FDA Clinical Decision Support classification boundaries.
* `DISCLAIMER_GENERAL_WELLNESS.md`: Structural limits for analyzing non-diagnostic wellness guidelines.
* `DATA_PRIVACY_AND_BORDER.md`: Technical data limits governing regional file execution.
* `EXPORT_CONTROL.md`: Legal declarations on software code transmission compliance.
* `LICENSE`: Open-source liability limitation release under the Unlicense framework.

---

## 🏛️ Legal Administration & Corporate Support
This software module, mathematical tracking guide, and analytical asset catalog are maintained under strict corporate and legal oversight. To satisfy global regulatory tracking procedures, do **NOT** use public GitHub issue fields, public pull requests, or public comment timelines to post clinical calculations feedback, bug observations, or system adjustments.

All source updates, formula customization requests, development pipeline tickets, formal complaints, and compliments must be routed exclusively to our designated legal representatives:

* **Firm:** Fox Rothschild LLP
* **Scope of Representation:** All Support, System Updates, Customizations, Complaints, and Compliments
